Published date : 08 August 2012
Article date : 08 August 2012
NeuroMetrix Inc's Sensus pain management device has been approved by the Food and Drug Administration. The company hopes that the device should reach the US market before the end of the year. The Sensus is a non-invasive electrical nerve stimulator that is designed to provide relief from chronic pain.
People likely to benefit from the device are diabetics with nerve-related complication, diabetic neuropathy. In many cases, these diabetics now use medication to manage pain. The hope is that the Sensus could eliminate or reduce their need for pain-management drugs.
The Sensus is designed to be worn around a patient’s upper calf and pain relief is initiated by pressing a button that causes electrical stimulation of the nerves. The physiological principle is that excitation of normal nerves reduces transmission of pain signals to the brain.